Chardan Capital analyst Geulah Livshits has reiterated their bullish stance on KRYS stock, giving a Buy rating yesterday. Geulah Livshits has ...

Krystal Biotech (KRYS) has received a new Buy rating, initiated by William Blair analyst, Sami Corwin. Sami Corwin has given his Buy rating due ...